HUE071303T2 - Ketamin-készítmény a depresszió tüdõn keresztül való beadással történõ kezelési módszerében való felhasználásra - Google Patents

Ketamin-készítmény a depresszió tüdõn keresztül való beadással történõ kezelési módszerében való felhasználásra

Info

Publication number
HUE071303T2
HUE071303T2 HUE18461615A HUE18461615A HUE071303T2 HU E071303 T2 HUE071303 T2 HU E071303T2 HU E18461615 A HUE18461615 A HU E18461615A HU E18461615 A HUE18461615 A HU E18461615A HU E071303 T2 HUE071303 T2 HU E071303T2
Authority
HU
Hungary
Prior art keywords
pulmonary administration
treating depression
ketamine
preparation
ketamine preparation
Prior art date
Application number
HUE18461615A
Other languages
English (en)
Hungarian (hu)
Inventor
Maciej Wieczorek
Sylwia Janowska
Original Assignee
Novohale Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novohale Therapeutics Llc filed Critical Novohale Therapeutics Llc
Publication of HUE071303T2 publication Critical patent/HUE071303T2/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HUE18461615A 2018-09-28 2018-09-28 Ketamin-készítmény a depresszió tüdõn keresztül való beadással történõ kezelési módszerében való felhasználásra HUE071303T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18461615.9A EP3628313B1 (en) 2018-09-28 2018-09-28 Ketamine composition for use in a method of treatment of depression by pulmonary administration

Publications (1)

Publication Number Publication Date
HUE071303T2 true HUE071303T2 (hu) 2025-08-28

Family

ID=63713806

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE18461615A HUE071303T2 (hu) 2018-09-28 2018-09-28 Ketamin-készítmény a depresszió tüdõn keresztül való beadással történõ kezelési módszerében való felhasználásra
HUE19770131A HUE071649T2 (hu) 2018-09-28 2019-09-24 Ketamin-készítmény a depresszió tüdõn keresztül való beadással történõ kezelési módszerében való felhasználásra

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE19770131A HUE071649T2 (hu) 2018-09-28 2019-09-24 Ketamin-készítmény a depresszió tüdõn keresztül való beadással történõ kezelési módszerében való felhasználásra

Country Status (14)

Country Link
US (1) US11925607B2 (https=)
EP (3) EP3628313B1 (https=)
JP (1) JP7444864B2 (https=)
KR (1) KR102867739B1 (https=)
CN (1) CN113038941A (https=)
AU (1) AU2019349624B2 (https=)
BR (1) BR112021005687A2 (https=)
CA (1) CA3114325A1 (https=)
EA (1) EA202190724A1 (https=)
ES (2) ES3021221T3 (https=)
HU (2) HUE071303T2 (https=)
MX (1) MX2021003668A (https=)
PL (2) PL3628313T3 (https=)
WO (1) WO2020064748A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3505157T3 (pl) 2017-12-29 2022-04-11 Celon Pharma S.A. Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0009469D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formalities for use in inhaler devices
GB0523031D0 (en) * 2005-11-11 2005-12-21 Yaupon Therapeutics Enhancement of morphine analgesia by s(-)-norketamine
WO2007111880A2 (en) 2006-03-22 2007-10-04 Mount Sinai School Of Medicine Intranasal administration of ketamine to treat depression
DE102007009888A1 (de) 2007-02-28 2008-09-04 Hermann, Holger Lars, Dr. Verwendung von S-(+)-Ketamin zur Behandlung von Depressionen
GB0908129D0 (en) * 2009-05-12 2009-06-24 Innovata Ltd Composition
PE20141906A1 (es) 2012-03-12 2014-12-05 Janssen Pharmaceutica Nv Esketamina para el tratamiento de la depresion refractaria al tratamiento o resistente al tratamiento
WO2014020155A1 (en) 2012-08-02 2014-02-06 Clinpharm Reform Gmbh Oral transmucosal adminstration forms of s-ketamine
PE20200404A1 (es) 2013-03-15 2020-02-26 Janssen Pharmaceutica Nv Composicion farmaceutica de clorhidrato de s-ketamina
CN116251084A (zh) 2013-03-15 2023-06-13 詹森药业有限公司 S-盐酸氯胺酮的药物组合物
CN106714789A (zh) * 2014-08-13 2017-05-24 詹森药业有限公司 用于治疗抑郁症的方法
US20160338977A1 (en) * 2015-05-20 2016-11-24 Janssen Pharmaceutica Nv Methods and kits for treating depression
CN106562952B (zh) * 2015-10-09 2020-06-09 江阴安博生物医药有限公司 氯胺酮在治疗重性抑郁障碍中的应用
PL3505157T3 (pl) * 2017-12-29 2022-04-11 Celon Pharma S.A. Kompozycja ketaminy w postaci suchego proszku do podawania dopłucnego w leczeniu depresji opornej na leczenie

Also Published As

Publication number Publication date
PL3628313T3 (pl) 2025-06-23
JP2022502429A (ja) 2022-01-11
HUE071649T2 (hu) 2025-09-28
EP3628313A1 (en) 2020-04-01
EP3856159A1 (en) 2021-08-04
MX2021003668A (es) 2021-08-19
EP4578505A3 (en) 2025-09-03
US11925607B2 (en) 2024-03-12
EP3856159B1 (en) 2025-03-12
ES3021221T3 (en) 2025-05-26
EA202190724A1 (ru) 2021-08-18
KR20210068465A (ko) 2021-06-09
AU2019349624B2 (en) 2025-08-28
PL3856159T3 (pl) 2025-06-16
EP3856159C0 (en) 2025-03-12
US20210353560A1 (en) 2021-11-18
BR112021005687A2 (pt) 2021-06-22
ES3028459T3 (en) 2025-06-19
EP3628313B1 (en) 2025-02-12
CA3114325A1 (en) 2020-04-02
EP4578505A2 (en) 2025-07-02
EP3628313C0 (en) 2025-02-12
JP7444864B2 (ja) 2024-03-06
KR102867739B1 (ko) 2025-10-13
WO2020064748A1 (en) 2020-04-02
AU2019349624A1 (en) 2021-04-29
CN113038941A (zh) 2021-06-25

Similar Documents

Publication Publication Date Title
IL282570A (en) Methods and devices for treating pulmonary edema
IL282794A (en) Therapeutic methods
IL263290A (en) Mechanically-adjustable e-vaping device flavor assembly
IL261283A (en) Compositions and methods using same for deposition of silicon-containing film
IL236003A (en) Model registration system and method
IL260069A (en) Compositions and methods using same for deposition of silicon-containing film
EP3800913C0 (en) CUSTOMER AUTHENTICATION
DK3126384T3 (da) Multispecifikke antistofanaloger omfattende en fælles letkæde, og fremgangsmåder til deres fremstilling og anvendelse
LT3882250T (lt) Tetrahidropiranilamino-pirolopirimidinonas, skirtas panaudoti btk nulemtų sutrikimų gydymui
IL247942A0 (en) Compositions and methods for treatment of diabetic macular edema
BR112016014971A2 (pt) método para montar um jogo de painéis para obter um componente de mobília
FI20155411A7 (fi) Menetelmä ja laitteisto ligniinifraktion muodostamiseksi, ligniinikoostumus ja sen käyttö
EP3357054C0 (en) HYSTERECTOMY MODEL
IL258024A (en) Composition and method for treating complement-mediated disease
EP3397414C0 (de) Verfahren zum herstellen von hydrospeichern
DE102013108713B8 (de) Verfahren zum Verifizieren der ldentität eines Nutzers
KR20180084824A (ko) 감방사선성 조성물, 패턴 형성 방법 및 감방사선성 산 발생제
EP3589477A4 (en) 3D PRINTING USING SPRAY SHAPING
DK2799842T3 (da) Anordning og fremgangsmåde til overvågning af en egenskab ved et over-træk på en fast doseringsform under en overtræksproces til dannelse af overtrækket på den faste doseringsform
DK3003734T3 (da) Fremgangsmåde til fremstilling af laminatgulvbrædder med kanter, der følger træmaterialets naturlige krumning
SG11202010825QA (en) Method for executing instructions in cpu
SG10201604551XA (en) Cleaning Composition for Photolithography and Method of Forming Photoresist Pattern Using the Same
DK3398449T3 (da) Fremgangsmåde til smoltificering hos salmonidae
DK2995637T3 (da) Coating-sammensætning til træoverfladebehandling
DK3445351T3 (da) Acetyl-leucin eller et farmaceutisk acceptabelt salt deraf til forbedret mobilitet